12:00 AM
 | 
Dec 21, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Erbitux cetuximab regulatory update

The National Comprehensive Cancer Network (NCCN) updated its clinical practice guidelines in oncology for maintenance therapies for non-small cell lung cancer (NSCLC) to include Avastin bevacizumab and Erbitux cetuximab as...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >